• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用伪观测值进行生存分析中的因果推断。

Causal inference in survival analysis using pseudo-observations.

作者信息

Andersen Per K, Syriopoulou Elisavet, Parner Erik T

机构信息

Section of Biostatistics, University of Copenhagen, Ø. Farimagsgade 5, Copenhagen, PB 2099, DK-1014, Denmark.

Department of Health Sciences, College of Medicine Biological Sciences and Psychology, University of Leicester, University Road, Leicester, LE1 7RH, U.K.

出版信息

Stat Med. 2017 Jul 30;36(17):2669-2681. doi: 10.1002/sim.7297. Epub 2017 Apr 6.

DOI:10.1002/sim.7297
PMID:28384840
Abstract

Causal inference for non-censored response variables, such as binary or quantitative outcomes, is often based on either (1) direct standardization ('G-formula') or (2) inverse probability of treatment assignment weights ('propensity score'). To do causal inference in survival analysis, one needs to address right-censoring, and often, special techniques are required for that purpose. We will show how censoring can be dealt with 'once and for all' by means of so-called pseudo-observations when doing causal inference in survival analysis. The pseudo-observations can be used as a replacement of the outcomes without censoring when applying 'standard' causal inference methods, such as (1) or (2) earlier. We study this idea for estimating the average causal effect of a binary treatment on the survival probability, the restricted mean lifetime, and the cumulative incidence in a competing risks situation. The methods will be illustrated in a small simulation study and via a study of patients with acute myeloid leukemia who received either myeloablative or non-myeloablative conditioning before allogeneic hematopoetic cell transplantation. We will estimate the average causal effect of the conditioning regime on outcomes such as the 3-year overall survival probability and the 3-year risk of chronic graft-versus-host disease. Copyright © 2017 John Wiley & Sons, Ltd.

摘要

对于未删失的响应变量(如二元或定量结果)的因果推断,通常基于以下两种方法之一:(1)直接标准化(“G公式”)或(2)治疗分配权重的逆概率(“倾向得分”)。在生存分析中进行因果推断时,需要处理右删失问题,为此通常需要特殊技术。我们将展示在生存分析中进行因果推断时,如何通过所谓的伪观测值“一劳永逸”地处理删失问题。在应用早期的“标准”因果推断方法(如(1)或(2))时,伪观测值可用于替代未删失的结果。我们研究了这个想法,以估计二元治疗对生存概率、受限平均生存期和竞争风险情况下累积发病率的平均因果效应。这些方法将在一个小型模拟研究中以及通过一项对急性髓细胞白血病患者的研究进行说明,这些患者在异基因造血细胞移植前接受了清髓或非清髓预处理。我们将估计预处理方案对3年总生存概率和3年慢性移植物抗宿主病风险等结果的平均因果效应。版权所有© 2017约翰威立父子有限公司。

相似文献

1
Causal inference in survival analysis using pseudo-observations.使用伪观测值进行生存分析中的因果推断。
Stat Med. 2017 Jul 30;36(17):2669-2681. doi: 10.1002/sim.7297. Epub 2017 Apr 6.
2
How serious is bias in effect estimation in randomised trials with survival data given risk heterogeneity and informative censoring?在存在风险异质性和信息删失的情况下,生存数据的随机试验中效应估计的偏倚有多严重?
Stat Med. 2017 Sep 20;36(21):3315-3333. doi: 10.1002/sim.7343. Epub 2017 Jun 15.
3
Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.在存在不依从性的随机试验中评估安全性上限的因果推断方法。
Clin Trials. 2015 Jun;12(3):265-75. doi: 10.1177/1740774515572352. Epub 2015 Mar 1.
4
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.马利兰剂量强度与骨髓增生异常综合征或急性髓系白血病患者行减低强度异基因外周血造血干细胞移植的结局。
Biol Blood Marrow Transplant. 2013 Jun;19(6):981-7. doi: 10.1016/j.bbmt.2013.03.016. Epub 2013 Apr 2.
5
Doubly-robust methods for differences in restricted mean lifetimes using pseudo-observations.使用伪观测值估计受限平均生存时间差异的双重稳健方法。
Pharm Stat. 2022 Nov;21(6):1185-1198. doi: 10.1002/pst.2223. Epub 2022 May 7.
6
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.体内T细胞清除对采用氟达拉滨-静脉白消安清髓方案预处理的首次完全缓解期急性髓系白血病患者进行HLA全相合异基因干细胞移植的影响:欧洲血液与骨髓移植协会急性白血病工作组报告
J Hematol Oncol. 2017 Jan 24;10(1):31. doi: 10.1186/s13045-016-0389-4.
7
Fast approximations of pseudo-observations in the context of right censoring and interval censoring.右删失和区间删失情况下伪观测值的快速近似
Biom J. 2023 Apr;65(4):e2200071. doi: 10.1002/bimj.202200071. Epub 2023 Feb 26.
8
Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.减低强度预处理异基因造血移植后高危急性髓系白血病和骨髓增生异常综合征的持续缓解:慢性移植物抗宿主病是改善生存的最强因素。
J Clin Oncol. 2008 Feb 1;26(4):577-84. doi: 10.1200/JCO.2007.11.1641. Epub 2007 Dec 17.
9
Inference for the effect of treatment on survival probability in randomized trials with noncompliance and administrative censoring.在存在不依从和行政审查的随机试验中,对治疗对生存概率影响的推断。
Biometrics. 2011 Dec;67(4):1397-405. doi: 10.1111/j.1541-0420.2011.01575.x. Epub 2011 Mar 8.
10
Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT.将移植选择扩展至50岁以上患者。急性髓系白血病患者接受减低强度预处理不匹配无关供者移植后的结局改善:欧洲血液与骨髓移植协会急性白血病工作组报告
Haematologica. 2016 Jun;101(6):773-80. doi: 10.3324/haematol.2015.138180. Epub 2016 Mar 11.

引用本文的文献

1
Doubly Robust Estimation of Marginal Cumulative Incidence Curves for Competing Risk Analysis.用于竞争风险分析的边际累积发病率曲线的双重稳健估计
Stat Med. 2025 Aug;44(18-19):e70066. doi: 10.1002/sim.70066.
2
Causal mediation analysis for time-to-event outcomes on the Restricted Mean Survival Time scale: A pseudo-value approach.受限平均生存时间尺度上事件发生时间结局的因果中介分析:一种伪值方法。
PLoS One. 2025 Apr 9;20(4):e0319074. doi: 10.1371/journal.pone.0319074. eCollection 2025.
3
Cross-Sectoral Comparisons of Process Quality Indicators of Health Care Across Residential Regions Using Restricted Mean Survival Time.
使用受限平均生存时间对不同居住区域的医疗保健过程质量指标进行跨部门比较。
Med Care. 2024 Nov 1;62(11):748-756. doi: 10.1097/MLR.0000000000002057. Epub 2024 Oct 11.
4
Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.多发性硬化症患者启动疾病修正治疗后 2 型糖尿病、心血管疾病和慢性肾脏病的发病率:使用频率派模型平均统计框架的回顾性队列研究。
PLoS One. 2024 Mar 22;19(3):e0300708. doi: 10.1371/journal.pone.0300708. eCollection 2024.
5
Multiply robust estimator for the difference in survival functions using pseudo-observations.使用伪观测值的生存函数差异的多重稳健估计量。
BMC Med Res Methodol. 2023 Oct 23;23(1):247. doi: 10.1186/s12874-023-02065-6.
6
Analysis of survival data with nonproportional hazards: A comparison of propensity-score-weighted methods.非比例风险生存数据分析:倾向评分加权法的比较。
Biom J. 2024 Jan;66(1):e202200099. doi: 10.1002/bimj.202200099. Epub 2022 Dec 21.
7
A Review of Causal Inference for External Comparator Arm Studies.外部对照臂研究的因果推断综述。
Drug Saf. 2022 Aug;45(8):815-837. doi: 10.1007/s40264-022-01206-y. Epub 2022 Jul 27.
8
Analysis of survival data with cure fraction and variable selection: A pseudo-observations approach.带有治愈分数和变量选择的生存数据分析:一种伪观测方法。
Stat Methods Med Res. 2022 Nov;31(11):2037-2053. doi: 10.1177/09622802221108579. Epub 2022 Jun 27.
9
Regression modeling of restricted mean survival time for left-truncated right-censored data.左截断右删失数据的限制平均生存时间的回归建模。
Stat Med. 2022 Jul 20;41(16):3003-3021. doi: 10.1002/sim.9399. Epub 2022 Mar 28.
10
Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system.安全网医疗体系中结肠癌患者辅助化疗开始时间与死亡率的关系。
BMC Cancer. 2022 May 31;22(1):593. doi: 10.1186/s12885-022-09688-w.